These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32914971)
1. New V Banerjee A; Dash SP; Mohanty M; Sahu G; Sciortino G; Garribba E; Carvalho MFNN; Marques F; Costa Pessoa J; Kaminsky W; Brzezinski K; Dinda R Inorg Chem; 2020 Oct; 59(19):14042-14057. PubMed ID: 32914971 [TBL] [Abstract][Full Text] [Related]
2. Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction. Banerjee A; Dash SP; Mohanty M; Sanna D; Sciortino G; Ugone V; Garribba E; Reuter H; Kaminsky W; Dinda R J Inorg Biochem; 2019 Oct; 199():110786. PubMed ID: 31377474 [TBL] [Abstract][Full Text] [Related]
3. ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins. Ugone V; Sanna D; Sciortino G; Crans DC; Garribba E Inorg Chem; 2020 Jul; 59(14):9739-9755. PubMed ID: 32585093 [TBL] [Abstract][Full Text] [Related]
4. A Series of Non-Oxido V Banerjee A; Patra SA; Sahu G; Sciortino G; Pisanu F; Garribba E; Carvalho MFNN; Correia I; Pessoa JC; Reuter H; Dinda R Inorg Chem; 2023 May; 62(20):7932-7953. PubMed ID: 37154533 [TBL] [Abstract][Full Text] [Related]
5. Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex. Patra SA; Mohanty M; Banerjee A; Kesarwani S; Henkel F; Reuter H; Dinda R J Inorg Biochem; 2021 Nov; 224():111582. PubMed ID: 34450411 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V Rudbari HA; Saadati A; Aryaeifar M; Correia I; Marques F; Blacque O; Micale N Bioorg Med Chem Lett; 2021 Oct; 49():128285. PubMed ID: 34303813 [TBL] [Abstract][Full Text] [Related]
8. Vanadium(V) complexes of a tripodal ligand, their characterisation and biological implications. Maurya MR; Uprety B; Avecilla F; Adão P; Costa Pessoa J Dalton Trans; 2015 Oct; 44(40):17736-55. PubMed ID: 26399883 [TBL] [Abstract][Full Text] [Related]
9. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)]. Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276 [TBL] [Abstract][Full Text] [Related]
10. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents. Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and application of vanadium-salan complexes in oxygen transfer reactions. Adão P; Costa Pessoa J; Henriques RT; Kuznetsov ML; Avecilla F; Maurya MR; Kumar U; Correia I Inorg Chem; 2009 Apr; 48(8):3542-61. PubMed ID: 19290614 [TBL] [Abstract][Full Text] [Related]
12. Decoding Surface Interaction of V Sciortino G; Sanna D; Ugone V; Lledós A; Maréchal JD; Garribba E Inorg Chem; 2018 Apr; 57(8):4456-4469. PubMed ID: 29613772 [TBL] [Abstract][Full Text] [Related]
13. The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities. Du S; Feng J; Lu X; Wang G Dalton Trans; 2013 Jul; 42(26):9699-705. PubMed ID: 23680987 [TBL] [Abstract][Full Text] [Related]
14. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium. Le M; Rathje O; Levina A; Lay PA J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136 [TBL] [Abstract][Full Text] [Related]
15. Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations. Sciortino G; Sanna D; Ugone V; Micera G; Lledós A; Maréchal JD; Garribba E Inorg Chem; 2017 Nov; 56(21):12938-12951. PubMed ID: 28985059 [TBL] [Abstract][Full Text] [Related]
16. Exploring the effect of hydroxylic and non-hydroxylic solvents on the reaction of [V Biswas N; Patra D; Mondal B; Bera S; Acharyya S; Biswas AK; Mukhopadhyay TK; Pal A; Drew MGB; Ghosh T Dalton Trans; 2017 Aug; 46(33):10963-10985. PubMed ID: 28766668 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells. Nunes P; Correia I; Cavaco I; Marques F; Pinheiro T; Avecilla F; Pessoa JC J Inorg Biochem; 2021 Apr; 217():111350. PubMed ID: 33477088 [TBL] [Abstract][Full Text] [Related]
18. Insights into the Theranostic Activity of Nonoxido V Pattanayak PD; Banerjee A; Sahu G; Das S; Lima S; Akintola O; Buchholz A; Görls H; Plass W; Reuter H; Dinda R Inorg Chem; 2024 Oct; 63(41):19418-19438. PubMed ID: 39340532 [TBL] [Abstract][Full Text] [Related]
19. Vanadium complexes having [VO]2+, [VO]3+ and [VO2]+ cores with hydrazones of 2,6-diformyl-4-methylphenol: synthesis, characterization, reactivity, and catalytic potential. Maurya MR; Haldar C; Kumar A; Kuznetsov ML; Avecilla F; Costa Pessoa J Dalton Trans; 2013 Sep; 42(33):11941-62. PubMed ID: 23680862 [TBL] [Abstract][Full Text] [Related]
20. Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach. Ugone V; Sanna D; Sciortino G; Maréchal JD; Garribba E Inorg Chem; 2019 Jun; 58(12):8064-8078. PubMed ID: 31140794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]